1. 2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer. Issue 5 (28th October 2019) Authors: Fugazzola, Laura; Elisei, Rossella; Fuhrer, Dagmar; Jarzab, Barbara; Leboulleux, Sophie; Newbold, Kate; Smit, Jan Journal: European thyroid journal Issue: Volume 8:Issue 5(2019) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?. Issue 1 (1st January 2022) Authors: Pacini, Furio; Fuhrer, Dagmar; Elisei, Rossella; Handkiewicz-Junak, Daria; Leboulleux, Sophie; Luster, Markus; Schlumberger, Martin; Smit, Johannes W Journal: European thyroid journal Issue: Volume 11:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion. (29th July 2020) Authors: Giani, Carlotta; Ramone, Teresa; Romei, Cristina; Ciampi, Raffaele; Tacito, Alessia; Valerio, Laura; Agate, Laura; Ugolini, Clara; Marinò, Michele; Basolo, Fulvio; Franchi, Alessandro; Borsari, Simona; Michelucci, Angela; Selli, Cesare; Materazzi, Gabriele; Cetani, Filomena; Elisei, Rossella Other Names: Boyanov Mihail A. Academic Editor. Journal: Case reports in endocrinology Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment. Issue 16 (24th April 2015) Authors: Cabanillas, Maria E.; Schlumberger, Martin; Jarzab, Barbara; Martins, Renato G.; Pacini, Furio; Robinson, Bruce; McCaffrey, Judith C.; Shah, Manisha H.; Bodenner, Donald L.; Topliss, Duncan; Andresen, Corina; O'Brien, James P.; Ren, Min; Funahashi, Yasuhiro; Allison, Roger; Elisei, Rossella; Newb... Journal: Cancer Issue: Volume 121:Issue 16(2015) Page Start: 2749 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma. Issue 8 (22nd March 2018) Authors: Condello, Vincenzo; Macerola, Elisabetta; Ugolini, Clara; De Napoli, Luigi; Romei, Cristina; Materazzi, Gabriele; Elisei, Rossella; Basolo, Fulvio Journal: Head & neck Issue: Volume 40:Issue 8(2018) Page Start: 1752 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bilateral testicular metastases of medullary thyroid carcinoma in an adult male with multiple endocrine neoplasia 2A syndrome: case report and review of literature. Issue 2 (18th March 2022) Authors: Orsolini, Francesca; Prete, Alessandro; Falcetta, Pierpaolo; Canale, Domenico; Basolo, Fulvio; Alì, Greta; Manassero, Francesca; Vitti, Paolo; Elisei, Rossella; Molinaro, Eleonora Journal: European thyroid journal Issue: Volume 11:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment. (18th November 2017) Authors: Huang, Yueye; Qu, Shen; Zhu, Guangwu; Wang, Fei; Liu, Rengyun; Shen, Xiaopei; Viola, David; Elisei, Rossella; Puxeddu, Efisio; Fugazzola, Laura; Colombo, Carla; Jarzab, Barbara; Czarniecka, Agnieszka; Lam, Alfred K; Mian, Caterina; Vianello, Federica; Yip, Linwah; Riesco-Eizaguirre, Garcilaso; Sa... Journal: Journal of the National Cancer Institute Issue: Volume 110:Number 4(2018) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma. (January 2020) Authors: Kim, Kyeong J.; Kim, Sin G.; Tan, Jie; Shen, Xiaopei; Viola, David; Elisei, Rossella; Puxeddu, Efisio; Fugazzola, Laura; Colombo, Carla; Jarzab, Barbara; Czarniecka, Agnieszka; Lam, Alfred K.; Mian, Caterina; Vianello, Federica; Yip, Linwah; Riesco-Eizaguirre, Garcilaso; Santisteban, Pilar; O'Nei... Journal: European journal of cancer Issue: Volume 124(2020) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer. (August 2013) Authors: Viola, David; Cappagli, Virginia; Elisei, Rossella Journal: Future oncology Issue: Volume 9:Number 8(2013) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer. (August 2013) Authors: Viola, David; Cappagli, Virginia; Elisei, Rossella Journal: Future oncology Issue: Volume 9:Number 8(2013) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗